Research perspective A 2001 editorial in the European Journal of Anaesthesiology described DSIP as "incredibly safe" based on the lack of lethal doses in animal studies and absence of significant side effects in human trials beyond transient symptoms
Redox regulation of immunometabolism
BPC-157 as a needle-free dissolving strip studied for recovery, tissue repair and gut health
Helps restore intestinal barrier function by strengthening tight junctions between cells, reducing intestinal permeability, and supporting healthy gut lining regeneration for improved nutrient absorption
Intramuscular (IM) B12 injections using hydroxocobalamin, the preferred licensed form in the UK are recommended when: Oral supplementation has failed to correct a documented deficiency The patient has difficulty adhering to daily oral regimens Serum B12 levels remain persistently low despite adequate oral dosing There is clinical evidence of neurological or haematological complications In line with BNF guidance, the standard IM regimen for confirmed deficiency without neurological involvement is a loading course of 1 mg hydroxocobalamin on alternate days for two weeks , followed by maintenance of 1 mg every three months
Foundational work appears in journals including Lancet HIV, AIDS, and JCEM, with multiple phase 2 and phase 3 clinical research papers examining endpoints in HIV-associated lipodystrophy and visceral adipose tissue research.